Search for a trial

A Phase 2b/3 study to evaluate the safety, tolerability, and effects of livoletide (AZP-531), an unacylated ghrelin analog, on food-related behaviors in patients with Prader-Willi syndrome

This Phase 2b/3 double-blind, placebo-controlled study will evaluate the safety, tolerability, and effects of livoletide on food-related behaviors in patients with Prader-Willi Syndrome (PWS).

Training working memory to improve eating behavior after bariatric surgery

Bariatric surgery does not directly target the underlying psychological factors that potentially contribute to the development and maintenance of obesity (Cassin et al., 2013). Despite some psychosocial factors predicting postoperative weight loss…